A method for extracting and detecting volatile organic compounds includes steps as follows. At least one effervescent tablet is provided, wherein the effervescent tablet is produced by mixing an acidic compound and an alkaline compound homogeneously. An extraction and detection apparatus is provided, wherein the extraction and detection apparatus includes an extraction chamber, an injection tube and a detection instrument. An extraction step is performed, wherein a liquid matrix is put into the extraction chamber, and the effervescent tablet is added into the liquid matrix to generate bubbles, the volatile organic compounds are extracted from the liquid matrix by the bubbles, and the bubbles enter into the headspace of the extraction chamber. A detection step is performed, wherein the volatile organic compounds extracted during the extraction step are transferred to the detection instrument via the injection tube so as to detect the volatile organic compounds.

Yttria containing hybrid organic-inorganic sol-gels may be used in coatings for capillary microextraction, optionally hyphenated to online HPLC analysis. The sol-gel reaction mixture can use an yttrium trialkoxyalkoxide, such as yttrium trimethoxyethoxide, and a [bis(hydroxyalkyl)-amino-alkyl]-terminated polydialkyl/arylsiloxane, such as [bis(hydroxyethyl)-amine] (BHEA)-terminated polydimethylsiloxane, that can undergo hydrolysis and polycondensation, to form coating materials. Capillaries coated with such sol-gels can have improved extraction efficiency compared, e.g., to pure yttria-based coatings. The CME-HPLC can analyze water samples containing analytes of varied polarity, with excellent extraction of amides, phenols, alcohols, ketones, aldehydes, and polyaromatic hydrocarbons and detection limits ranging from 0.18 to 7.35 ng/mL (S/N=3). Such capillaries can exhibit solvent stability at pH 0 to 14, RSD % between 0.6 to 6.8% (n=3), at a preparative reproducibility RSD between 4.1 and 9.9%.

A method for extracting an analyte from a solid sample is described. The sample is sealed in a porous membrane bag, which is sonicated in an organic solvent. An extract of the analyte forms in the bag and diffuses into the organic solvent. The organic solvent containing the extract may then be concentrated and analyzed for an analyte with gas chromatography-mass spectrometry. The method does not the use of a solid sorbent material, and does not require a step of centrifuging or filtering.

The present invention relates to a micro device for solid phase extraction and more particularly provides a micro device which is configured to perform solid phase extraction by injecting a filler and a solvent and producing a uniform flow of the solvent.

Embodiments of the present disclosure relate to a preparation and feed apparatus of a standard sample for calibration of a trace-analysis instrument, and especially to a preparation and feed apparatus of a standard sample for calibration of a gas chromatograph-ion mobility spectrometer. When the trace-analysis instrument is being calibrated by taking advantage of the preparation and feed apparatus according to embodiments of the disclosure, it is unnecessary to use an additional dedicated tool and steps to prepare the sample for testing and to use an organic solvent or a dedicated sample application/dispensing tool, resulting in that the trace-analysis instrument is simple and convenient to carry and use, and the substance for calibration is also convenient to store and exchange; moreover, the trace-analysis instrument is also safe, reliable and environmentally friendly.

A diagnostic apparatus for analysing a sample to diagnose disease, the apparatus comprising: a separating element for separating gas derived from the sample into component parts; a sensor arrangement coupled to the separating element such that a component part of the gas is directed towards the sensor arrangement, the sensor arrangement being configured to detect compounds which may be indicative of disease; and a processing element coupled to an output of the sensor arrangement, the processing element being configured to process a signal output by the sensor arrangement to provide a diagnosis.

A sample extraction device and a desorption device for use in gas chromatography (GC), gas chromatography-mass spectrometry (GCMS), liquid chromatography (LC), and/or liquid chromatography-mass spectrometry (LCMS) are disclosed. In some examples, the sample extraction device includes a lower chamber holding a sorbent. The sample extraction device can extract sample headspace gas from a sample vial by placing the sorbent inside the vial and creating a vacuum to increase recovery of low volatility compounds, for example. Once the sample has been collected, the sample extraction device can be inserted into a desorption device. The desorption device can control the flow of a carrier fluid (e.g., a liquid or a gas) through the sorbent containing the sample and into a pre-column and/or a primary column of a chemical analysis device for performing GC, GCMS, LC, LCMS, and/or some other chemical analysis process.

The present invention is directed to a method and device to generate a chemical signature for a mixture of analytes. The present invention involves using a SPME surface to one or both absorb and adsorb the mixture of analytes. In an embodiment of the invention, the surface is then exposed to different temperature ionizing species chosen with appropriate spatial resolution to desorb a chemical signature for the mixture of analytes.

A device for extracting a molecule of interest from a sample matrix. The device includes a support comprising a support surface; a sealing layer that at least partially coats the support surface; and an extractive phase coating applied to a portion of the sealing layer. The extractive phase coating is adapted to contain the molecule of interest. The sealing layer sufficiently coats the support surface to prevent the support surface from coming in contact with the sample matrix when the extractive phase coating is fully immersed in the sample matrix. Analytical screening devices and methods of manufacture are also disclosed.

The invention relates to Inter-alpha inhibitor proteins (IIp). The invention further relates to processes for purification of IIp compositions and their use for treatment of human diseases such as sepsis and septic shock, rheumatoid arthritis, cancer and infectious diseases.